IN8BIO INC. - COMMON
0.2550
07-10月-24 15:59:48
15 分の遅延
株式
-0.0083
-3.15%
本日の幅
0.2402 - 0.2760
ISIN
N/A
ソース
NASDAQ
-
IN8bio Announces Pricing of $12.4 Million Private Placement
01 10 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
IN8bio Announces Clinical Pipeline Prioritization to Focus on INB-100 for Acute Myeloid Leukemia
04 9 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
IN8bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference
29 8 2024 06:05:00 提供 Nasdaq GlobeNewswire
-
IN8bio Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
08 8 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
IN8bio to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
24 6 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
13 6 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
03 6 2024 06:05:00 提供 Nasdaq GlobeNewswire
-
IN8bio to Present at International Society for Cell & Gene Therapy (ISCT) 2024
24 5 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
23 5 2024 17:00:00 提供 Nasdaq GlobeNewswire
-
IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress
14 5 2024 10:00:00 提供 Nasdaq GlobeNewswire
-
13 5 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
09 5 2024 16:00:00 提供 Nasdaq GlobeNewswire
-
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma
30 4 2024 06:05:00 提供 Nasdaq GlobeNewswire
-
24 4 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
16 4 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024
09 4 2024 16:30:00 提供 Nasdaq GlobeNewswire
-
IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
14 3 2024 16:00:00 提供 Nasdaq GlobeNewswire
-
05 3 2024 16:30:00 提供 Nasdaq GlobeNewswire
-
14 2 2024 08:00:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >